News

Immunotherapies are revolutionizing the treatment of solid tumors, significantly increasing survival rates and reducing recurrence. These therapies work by lifting...

With the support of Airalzh, Marco Rasile of Humanitas University will investigate a new potential mechanism underlying the disease: the...

Professor Terracciano succeeds Alberto Mantovani, who has held the position since 2005 and will continue his work as President of...

For the first time, the EU project PHOENIX will integrate four precision technologies on organ-on-chip devices, personalised models that reproduce...

The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project has officially started: it’s an international research initiative, with a total budget...

According to the results of a study conducted at the Humanitas Research Hospital, tumors suppress the response of “Natural Killer”...

Fondazione Telethon has announced the winners of the fourth round of its multi-round grant program, which supports cutting-edge research on...

A study conducted at Humanitas has uncovered that the progression of heart failure is fueled by an autoimmune response targeting...

The development of gut microbiota and the immune system during the first months of life may be influenced by antibiotic...

On the occasion of the inauguration of the 2024/2025 academic year, the new 3D Innovation Lab, located in the Roberto...